Genomics Market: Growth, Size, Share, and Trends

Report Code BT 2209
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Genomics Market by Product (Kits, Consumables, Instruments), Services (Bioinformatics), Technology (Sequencing, PCR, ISH), Study Type (Epigenomics, Functional Genomics), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

Market Growth Outlook Summary

The global genomics market growth forecasted to transform from USD 42.64 billion in 2024 to USD 66.85 billion by 2029, driven by a CAGR of 9.4%. The primary growth drivers of this market are the surge in the prevalence of viral and inherited disorders that demand genomic sequencing, and the rising application of NGS in chronic disorders like cancer to identify genetic mutations. Moreover, the launch of advanced technologies in the genomics industry is further refining research and applications, supporting market growth. Additionally, the increased adoption of personalized medicine, which requires tailored treatment plans based on genomic data, is becoming more prevalent, thereby enhancing patient outcomes.

Genomics Market – Global Forecast and Key Opportunities to 2029

Asia Pacific

The growth of the Asia Pacific genomics market is primarily due to the rising funding for Translational research bolstered by the region’s diverse population with unique genetic backgrounds and healthcare challenges.

Growth in this market is primarily driven by technological advancement in genome sequencing.

Rising demand of healthcare testing to support clinical genomics is driving the demand of genomics market

High investments to develop advanced sequencing technologies restrain the market growth.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The rising investments by governments in Translational research to drive growth.

Genomics Market Dynamics to 2029

DRIVER: Increasing prevalence of viral and inherited disorders

Increased viral and inherited diseases The main driving force of the genomics market is the rapidly rising trend of viral and inherited disorders. Genomics technologies, in the form of NGS and long-read sequencing, can reveal genetic mutations and viral pathogens rapidly and accurately and thus help in the early diagnosis and management of such conditions, including cystic fibrosis and sickle cell anemia among others. Identifying mutation at a molecular level for targeted therapies contributes to the rise in demand for genomics-based diagnostic tools. The COVID-19 pandemic, for instance, highlighted the importance of genomic surveillance in outbreak management since it helped to identify new viral strains and mutations. Genomics is also applied in the study of other viral infections, including HIV and hepatitis, to ensure better treatment strategies and vaccines. With healthcare systems around the world embracing precision medicine, genomics tools are in greater and greater demand. Such interest from governments and healthcare institutions in genomics research and diagnostics has been directed at addressing the increasing burden of such disorders and gives the field a significant place in future healthcare strategies and drives market growth.

RESTRAINT: High investment cost

For the implementation of advanced technologies such as next-generation sequencing, long-read sequencing, and gene-editing tools like CRISPR, significant investments in terms of capital expenditure create major constraints. Setting up a genomics facility involves very high capital expenditure in terms of specialized instruments, reagents, and bioinformatics infrastructure. Many sequencing platforms and most high-throughput instruments are capital-intensive, and their maintenance, calibration, and upgrades are significant long-term operational costs. Such high prices would make the cost prohibitive to smaller research institutions, healthcare facilities, and companies, thus limiting massive uptake.

Furthermore, genomic workflows generate immense amounts of data. The storage and analytics requirements necessitate powerful computer systems. Apart from the HPC and bioinformatics software, the expenditure for the project also goes into the instruments. Running and processing the data require operations expenses since it demands expert people, training, and recruiting genomics and bioinformatics experts comes at a premium. More importantly, genomic tests such as whole-genome sequencing and personalized diagnostic tools, in their current form, have a very high cost in clinical settings. This will further limit wider usage, especially for areas with constrained budgets on healthcare or those with less advanced diagnostics coverage by insurance. High investment in genomics limits its adoption, primarily for low- and middle-income countries, and thus limits overall market growth, though vast.

 

OPPORTUNITY: Increasing use of genomics in precision medicine

Increasing use of genomics in precision medicine is one major growth opportunity in the genomics market. Precision medicine, which tailors medical treatment to the individual characteristics of each patient, depends considerably on genomics to analyze genetic variations affecting patients' risks, disease progressions, and treatment responses. Use data from genomics to provide therapy that is individualized, leading to better patient outcomes with less dependency on hit-or-miss traditional treatments. The biggest applications remain in oncology, whereby genomics is the source to identify cancer-causing mutations that guide targeted therapy selection. This is slowly crossing over into other fields, including cardiology, neurology, and immunology, where genetic information dictates the choice of drugs to use for each individual. With the ever-growing correlation between diseases and genetics, more individuals will require the utilization of genomic tools in precision medicine.

Pharmaceutical companies are spearheading the integration of genome data into drug discovery and drug development, which is speeding up innovation. In support of this, regulatory organizations are giving genomics-based diagnostic tests and more personalized treatment options favorable support, accelerating adoption. As countries continue to move toward precision medicine, the genomics markets will grow substantially-both in diagnostics, through therapeutic development and clinical studies-to offer better individualized and effective healthcare solutions.

CHALLENGES: Handling of a large volume of data sets and their analysis

One of the main challenges related to handling large-scale data volumes and their analysis dominates the genomics market. Next-generation sequencing (NGS) and similar technologies, put into operation in genomic applications, generate from hundreds of gigabytes to several terabytes in just one experiment, especially in big projects like whole-genome sequencing and population genomics. The scale of generated data creates storage, processing, and interpretation problems demanding large computational infrastructure and very special bioinformatics tools. This necessitates one of the biggest demands, namely high-performance computing (HPC) systems that can efficiently handle and process large datasets. Major laboratories and health institutions, especially those in low-resource settings, cannot afford or access the necessary infrastructure to handle such computationally demanding genomics research and diagnostics. Upon computation, the results need to be interpreted, which is another challenge. All this requires extremely complex algorithms in advanced bioinformatics so that meaningful information, like the identification of a disease-associated variant or a prediction for drug response, can be extracted from the data.

Data security and privacy issues also have a great hold; most of these issues, especially in the clinical segment, are quite prominent due to the processing of private genetic information, which comes with strict regulations. Continue efforts in data handling and analysis required stream the genomics market through innovations of data management, computationally equipped tools, and collaboration among genomics, IT, and healthcare industries.

Genomics Market Map & Ecosystem Overview

Global Genomics market Ecosystem Analysis includes technology developers, consumables suppliers, product & service providers, and end-users such as research institutions, clinical labs, hospitals, and biotechnology companies. Regulatory authorities and standards bodies also play pivotal roles, influencing market trends, innovation, and the ethical use of genomic data. Understanding this complex network is crucial for navigating and driving advancements in genomics technologies.

 

The product segment accounted for the largest share by offerings segment in the genomics market in 2023.

By offerings, the genomics market is segmented into products and services. The genomics market has the highest market share in products since it plays a critical role in the accomplishment of various research, diagnostic, and therapeutic applications. A huge demand for instruments, consumables, and reagents is generated due to the wide use of genomic technologies such as next-generation sequencing, polymerase chain reaction, and microarrays. The importance of these tools is the main key in conducting genomic analysis starting from sample preparation and moving up to data interpretation for wide applications. The rising interest in personalized medicine, cancer research, and disease diagnosis has steadily increased the demand for genomics products. Genome-based tests for precision medicine require a robust pipeline of reliable products that will accurately and expeditiously identify genetic variations. In the research environment, advanced instruments and reagents are needed to study gene expression, epigenetic modifications, and genome-wide associations. Continuous advances in product innovation, like more efficient and cost-effective sequencing technologies, have only continued to expand the genomics user base across pharmaceutical companies, academic institutions, and healthcare providers. This should ensure that products remain at the heart of driving the genomics market forward while offering cutting-edge research and clinical advancements.

The sequencing technology segment accounted for the largest share by technology segment in the genomics market in 2023.

By technology, the genomics products market is segmented into sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies. The sequencing accounted for the largest share of the market in 2023. Sequencing technologies such as NGS and long-read sequencing technologies have changed the way of genomics research. This has become an important tool for the study of any complex disease; or discovery of mutations in DNA that lead to cancer, infectious diseases, as well as inherited disorders. Its use in precision medicine is among the major reasons for the proliferation of sequencing technologies. In oncology, for instance, sequencing allows the identification of a specific genetic alteration in tumors, which would determine targeted therapy and outcome of treatment. The ability to give comprehensive genomic information at a decreasing cost and high throughput has made sequencing more accessible for clinical diagnostics, which in turn has boosted its adoption. Other drivers for this segment's growth are the increasing demand for sequencing in research, particularly in population genomics, pharmacogenomics, and rare disease studies. Improvements in sequencing technology have continually pushed the boundaries of genomics and, thus, are continuing to support the leading position of this segment in the market in terms of increased read lengths, accuracy, and automation.

The oncology segment accounted for the largest share of the diagnostic application segment in the genomics market in 2023.

By diagnostic application, the genomics market is segmented into oncology, infectious disease, reproductive health, and other diagnostic applications. In 2023, the oncology segment accounted for the largest share of the genomics market. This can be attributed to the ability to rising prevalence of cancer types and increasing demand for their extensive genomic profiling. Genomics is significant in cancer detection, diagnosis, and treatment due to the genetically driven nature of the disease. In effect, mutations and DNA changes cause the abnormal cell proliferation that constitutes cancer by definition. Genomics technologies, such as next-generation sequencing and other molecular diagnostic tools, have the potential to perform in-depth profiling of these kinds of mutations, and better and earlier detection of cancers. One of the leading factors for oncology dominating diagnostic use is precision medicine. It facilitates tumor genomic profiling, therefore targeting mutations for oncologists when treating individual patients by guiding oncologists to proper therapy targeted for the given patients. The results have greatly improved with such cancers like lung, breast, and colorectal cancer whose particular alterations can be matched against proper treatments. Advanced developments in liquid biopsy techniques by the application of genomics for detecting circulating tumor DNA in the blood have allowed for more extensive applications in non-invasive cancer diagnosis. Technologies are increasingly employed in the monitoring of the therapeutic response and detection of minimal residual disease. A greater share in the diagnostic segment has come for oncology on account of rising worldwide burdens of cancer together with availability-based improvements of genomics-based tests; that promise transformational benefits of early detection, better prognosis, and optimum selection of therapy.

The North American region accounted for the largest share of the genomics market in 2023.

The genomics market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is the largest regional market for genomics in 2023, while Europe is the second-largest market. The large share of North America can be attributed to the growing acceptance and integration of WGS in healthcare, as well as the government initiatives and policies to integrate genomics in healthcare further supporting the market growth. Another factor that explains why North America has a gigantic share is the generous funding and support for genomics research coming from the government and private sectors. For example, the All of Us Research Program is a large-scale program aimed at generating huge quantities of genomic data to improve healthcare outcomes and subsequently spur an increase in demand for genomics technologies. In fact, many research institutes and universities in the United States and Canada have been highly involved in genomics work that has accelerated innovations in cancer genomics, pharmacogenomics, and population genomics. Advanced healthcare infrastructure in North America has also helped advance genomics technologies into the clinic. Growth has been fueled further by increased demand for personalized medicine, particularly in oncology, through an increased demand for genomics-based diagnostics and targeted therapy.

Genomic innovations are boosted by regulatory agencies. Some of the genomics-based diagnostic tests and therapies were approved by US FDA, which in turn has been increasing its applications in North America. Its technological leadership, research spending, and favorable regulatory framework have ranked North America the largest market for genomics. However, the Asia Pacific is estimated to be the fastest-growing segment of the market owing to the increasing application in clinical diagnostics, and the the growing focus on custom tailored medicine.

HIGHEST CAGR MARKET IN 2023
NORTH AMERICA FASTEST GROWING MARKET IN THE REGION

Genomics Market Recent Developments and Insights

  • In May 2024, Oxford Nanopore Technologies collaborated with Twist Bioscience to launch a new Pharmacogenomics Beta Programme. This long-read pharmacogenomics solution, available for research use, is designed to provide clear genetic results in a single end-to-end workflow from sample to pharmacogenomics star allele call.
  • In September 2023, PacBio announced a partnership with Hamilton, Integra, Revvity, and Tecan to create fully automated protocols to prepare samples for sequencing on Revio and Sequel II and IIe systems.

Genomics Market – Leading Key Players Analysis

KEY PLAYERS IN THE GENOMICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Genomics Market?

Scope of the Report

Report Metric Details
Market Size (2024-2029) USD 42.64 billion in 2024 to USD 66.85 billion in 2029, at a CAGR of 9.4%
Growth Drivers Increase in viral and inherited disorders, NGS in chronic diseases, and demand for personalized medicine.
Key Opportunity Genomics in precision medicine for oncology, cardiology, and neurology, leading to tailored treatment plans.
Restraints High investment required for advanced technologies like NGS and gene editing, and data storage costs.
Challenges Handling large data volumes and complex analysis requires high-performance computing and specialized bioinformatics tools.
Leading Technology Sequencing technologies (NGS and long-read sequencing) dominate, enabling precision medicine.
Top Diagnostic Application Oncology, due to genomic profiling’s role in cancer detection, treatment, and personalized therapies.

Key Questions Addressed by the Report

The global genomics market is projected to grow from USD 42.64 billion in 2024 to USD 66.85 billion by 2029, demonstrating a robust CAGR of 9.4%.
Next-generation sequencing (NGS), long-read sequencing, CRISPR technologies, and bioinformatics are key drivers of the genomics market, enhancing the applications in diagnostics, drug discovery, and precision medicine.
Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), and Danaher Corporation (US) are prominent players in the genomics market. These companies utilize both organic and inorganic growth strategies to enhance their market positions.
The key applications of genomics include drug discovery and development, diagnostics, agriculture and animal research, and personalized medicine. In particular, genomics plays a significant role in cancer research, genetic disorder studies, and population genomics.
Genomics is a cornerstone of precision medicine, enabling targeted therapies based on individual genetic profiles. It aids in understanding genetic variations, cancer mutations, and rare disease mechanisms, paving the way for more personalized treatment options.
Sequencing technologies, especially next-generation sequencing (NGS), hold the largest market share in the genomics market. NGS's widespread use in diagnostics, genetic testing, and personalized medicine continues to dominate the market.
AI and machine learning (ML) are revolutionizing genomics by improving the accuracy of genetic data interpretation, enhancing sequencing capabilities, and accelerating the pace of genomics innovations. This integration is expected to enhance research productivity and clinical applications.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Genomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
42
RESEARCH METHODOLOGY
48
EXECUTIVE SUMMARY
60
PREMIUM INSIGHTS
66
MARKET OVERVIEW
70
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing government funding for genomics projects
    - Increasing prevalence of viral and inherited disorders
    - Advancements in NGS platforms
    - Growing applications of genomics
    RESTRAINTS
    - High investment costs
    OPPORTUNITIES
    - Increasing use of genomics in precision medicine
    - Technological advancements in genomics
    CHALLENGES
    - Handling of large volumes of data sets and their analysis
    - Clinical utility of genomics
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 REGULATORY LANDSCAPE
    REGULATORY SCENARIO
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGICAL ANALYSIS
    KEY TECHNOLOGIES
    - Sequencing by synthesis
    - Single-molecule real-time sequencing
    - Nanopore sequencing
    - qPCR
    - dPCR
    - Microarray technology
    COMPLEMENTARY TECHNOLOGIES
    - Cytogenetics
    - Synthetic biology
    - Multiomics
    - Single-cell analysis
    ADJACENT TECHNOLOGIES
    - Sample preparation technologies
    - Data analysis
    - Bioinformatics and computational biology
    - Artificial intelligence and machine learning
  • 5.7 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING
    - Average selling price of key players, by instrument
    - Average selling price of key players, by consumable
    - Average selling price of key players, by service
    AVERAGE SELLING PRICE, BY REGION
  • 5.8 PATENT ANALYSIS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA, BY END USER
  • 5.14 INVESTMENT AND FUNDING SCENARIO
  • 5.15 CASE STUDY ANALYSIS
  • 5.16 TRADE ANALYSIS
    IMPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), 2017–2021
    EXPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), 2017–2021
    IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022–2023
    EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022–2023
  • 5.17 IMPACT OF AI ON GENOMICS MARKET
GENOMICS MARKET, BY OFFERING
119
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
  • 6.3 SERVICES
GENOMICS MARKET, BY PRODUCT TYPE
127
  • 7.1 INTRODUCTION
  • 7.2 REAGENTS, KITS, AND CONSUMABLES
    LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR CONSUMABLES, KITS, AND REAGENTS
  • 7.3 INSTRUMENTS
    TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
  • 7.4 BIOINFORMATICS TOOLS
    BIOINFORMATICS TOOLS TO HELP TURN RAW DATA INTO MEANINGFUL INSIGHTS
GENOMICS PRODUCTS MARKET, BY TECHNOLOGY
141
  • 8.1 INTRODUCTION
  • 8.2 SEQUENCING
    DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
  • 8.3 PCR
    RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH
  • 8.4 GENE EDITING
    RISING DEMAND FOR NEWER THERAPEUTIC APPROACH DRIVING GROWTH
  • 8.5 FLOW CYTOMETRY
    RISING DEMAND FOR FLOW CYTOMETRY FOR AGRIGENOMICS TO DRIVE MARKET GROWTH
  • 8.6 MICROARRAYS
    RISING ADOPTION OF HIGH THROUGHPUT TECHNOLOGIES LIMITING MARKET GROWTH
  • 8.7 IN SITU HYBRIDIZATION
    INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS DRIVING GROWTH OF SEGMENT
  • 8.8 OTHER TECHNOLOGIES
GENOMICS PRODUCTS MARKET, BY END USER
168
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
    INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
  • 9.3 ACADEMIC AND RESEARCH INSTITUTES
    RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
  • 9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS IS DRIVING GROWTH
  • 9.5 CROS
    RISING COLLABORATION BETWEEN PHARMA COMPANIES AND CROS DRIVING MARKET GROWTH
  • 9.6 OTHER END USERS
GENOMICS MARKET, BY SERVICE TYPE
188
  • 10.1 INTRODUCTION
  • 10.2 GENOMIC PROFILING AND SEQUENCING SERVICES
    INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH
  • 10.3 SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES
    INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH
  • 10.4 BIOINFORMATICS SERVICES
    RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
GENOMICS MARKET, BY APPLICATION
200
  • 11.1 INTRODUCTION
  • 11.2 DRUG DISCOVERY AND DEVELOPMENT
    DRUG DISCOVERY AND DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET
  • 11.3 DIAGNOSTICS
    RISING DEMAND DUE TO CLINICAL GENOMICS TO SUPPORT MARKET GROWTH
    - Oncology
    INFECTIOUS DISEASES
    - Rising demand for comprehensive genomic data in clinical genomics to drive market growth
    REPRODUCTIVE HEALTH
    - Rising focus on genetic diseases to drive market growth
    OTHER DIAGNOSTIC APPLICATIONS
    - Rising demand for comprehensive genomic data in clinical genomics to drive market growth
    AGRICULTURE AND ANIMAL RESEARCH
    - Genomics to help improve crop productivity
  • 11.4 OTHER APPLICATIONS
GENOMICS MARKET, BY STUDY TYPE
230
  • 12.1 INTRODUCTION
  • 12.2 FUNCTIONAL GENOMICS
    INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES TO DRIVE MARKET GROWTH
  • 12.3 BIOMARKER DISCOVERY
    RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
  • 12.4 PATHWAY ANALYSIS
    RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH
  • 12.5 EPIGENOMICS
    RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH
  • 12.6 OTHER STUDY TYPES
GENOMICS SERVICES MARKET, BY END USER
249
  • 13.1 INTRODUCTION
  • 13.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
    INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
  • 13.3 ACADEMIC AND RESEARCH INSTITUTES
    RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
  • 13.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH
  • 13.5 OTHER END USERS
GENOMICS MARKET, BY REGION
265
  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - US expected to dominate market in North America
    CANADA
    - Increasing government initiatives in genomics research to boost market growth
  • 14.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Germany to dominate European genomics market
    UK
    - Strategic initiatives and funding for genomics research to support market growth
    FRANCE
    - Increasing government investment in genomics research to drive growth
    ITALY
    - Favorable funding scenario to drive adoption of advanced sequencing technology
    SPAIN
    - Growing focus on advancements in personalized medicine to support market growth
    REST OF EUROPE
  • 14.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - China to dominate Asia Pacific market during forecast period
    JAPAN
    - Rising number of collaborations in genomics to drive market
    INDIA
    - Government and private initiatives for genomics to propel market
    AUSTRALIA
    - Increased genomics research in Australia to support market growth
    SOUTH KOREA
    - Demand for advanced sequencing technologies to support market growth in South Korea
    REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Increased government investments in genomics advancements to drive market in Brazil
    MEXICO
    - Rising demand for chronic disease treatment to support market growth in Mexico
    REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST
    MIDDLE EAST: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Saudi Arabia
    - United Arab Emirates
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 14.7 AFRICA
    GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA
    AFRICA: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
395
  • 15.1 INTRODUCTION
  • 15.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • 15.3 REVENUE ANALYSIS
  • 15.4 MARKET SHARE ANALYSIS
  • 15.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
    ILLUMINA, INC.
    THERMO FISHER SCIENTIFIC INC.
    DANAHER CORPORATION
    ROCHE
    QIAGEN
  • 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
  • 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 15.8 VALUATION AND FINANCIAL METRICS OF GENOMICS VENDORS
  • 15.9 COMPETITIVE SCENARIO
    DEALS
    EXPANSIONS
COMPANY PROFILES
415
  • 16.1 KEY PLAYERS
    ILLUMINA, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products/Services offered
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products/Services offered
    QIAGEN
    - Business overview
    - Products/Services offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    REVVITY
    - Business overview
    - Products/Services offered
    - Recent developments
    LABORATORY CORPORATION OF AMERICA HOLDINGS
    - Business overview
    - Services offered
    - Recent developments
    IQVIA INC.
    - Business overview
    - Services offered
    - Recent developments
    CHARLES RIVER LABORATORIES
    - Business overview
    - Services offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services offered
    - Recent developments
    PACBIO
    - Business overview
    - Products/Services offered
    - Recent developments
    OXFORD NANOPORE TECHNOLOGIES PLC.
    - Business overview
    - Products/Services offered
    - Recent developments
    TAKARA BIO INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    BGI GROUP
    - Business overview
    - Products/Services offered
    - Recent developments
    EPPENDORF SE
    - Business overview
    - Products/Services offered
    - Recent developments
    MERCK KGAA
    - Business overview
    - Products/Services offered
    - Recent developments
    BD
    - Business overview
    - Products/Services offered
    - Recent developments
    ABBOTT
    - Business overview
    - Products/Services offered
    - Recent developments
    10X GENOMICS
    - Business overview
    - Products/Services offered
    - Recent developments
    NEW ENGLAND BIOLABS
    - Business overview
    - Products/Services offered
    - Recent developments
    PROMEGA CORPORATION
    - Business overview
    - Products/Services offered
    - Recent developments
  • 16.2 OTHER PLAYERS
    CREATIVE BIOGENE
    NOVOGENE CO., LTD.
    HELIX, INC.
    PHALANX BIOTECH GROUP
    POLARIS GENOMICS
APPENDIX
553
  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 3 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
  • TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT, 2021–2023 (USD)
  • TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021–2023 (USD)
  • TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD)
  • TABLE 12 INDICATIVE PRICE TREND, BY REGION, 2021–2023 (USD)
  • TABLE 13 INNOVATIONS AND PATENT REGISTRATIONS, 2020–2024
  • TABLE 14 GENOMICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 15 GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 16 GENOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 18 KEY BUYING CRITERIA, BY END USER
  • TABLE 19 SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
  • TABLE 20 LONG-READ WHOLE GENOME SEQUENCING WAS USED IN CHILDREN'S MERCY KANSAS CITY
  • TABLE 21 IMPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 22 EXPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
  • TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
  • TABLE 25 IMPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND)
  • TABLE 26 EXPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND)
  • TABLE 27 IMPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND)
  • TABLE 28 IMPORT VOLUME FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS)
  • TABLE 29 EXPORT VALUE FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND)
  • TABLE 30 EXPORT VOLUME FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS)
  • TABLE 31 GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 32 GENOMICS MARKET FOR PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 EUROPE: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 LATIN AMERICA: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 MIDDLE EAST: GENOMICS MARKET FOR PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 GCC COUNTRIES: GENOMICS MARKET FOR PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 GENOMICS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 EUROPE: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 MIDDLE EAST: GENOMICS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 GCC COUNTRIES: GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 GENOMICS MARKET FOR PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 47 GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 EUROPE: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 LATIN AMERICA: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 MIDDLE EAST: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 GCC COUNTRIES: GENOMICS MARKET FOR CONSUMABLES, KITS, AND REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 GENOMICS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 EUROPE: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 MIDDLE EAST: GENOMICS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 GCC COUNTRIES: GENOMICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 EUROPE: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 GCC COUNTRIES: GENOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 69 GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 EUROPE: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 GENOMICS PRODUCTS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 EUROPE: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 EUROPE: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR GENE EDITING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 EUROPE: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 96 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 EUROPE: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 103 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 EUROPE: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 110 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 117 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 119 GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 132 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 139 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 141 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 146 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,BY REGION, 2022–2029 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 GENOMICS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 EUROPE: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 LATIN AMERICA: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 161 GCC COUNTRIES: GENOMICS MARKET FOR GENOMIC PROFILING AND SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 EUROPE: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: GENOMICS MARKET FOR SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: GENOMICS MARKET FOR BIOINFORMATICS SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 177 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 185 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION )
  • TABLE 190 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 GENOMICS MARKET FOR DIAGNOSTICS APPLICATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 GRANTS, BY CANCER TYPE (AS OF JANUARY 2023)
  • TABLE 193 ONCOLOGY: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 194 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 199 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 INFECTIOUS DISEASES: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 201 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 REPRODUCTIVE HEALTH: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 208 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 213 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN REPRODUCTIVE HEALTH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS IN OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 222 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 EUROPE: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 229 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 237 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 241 MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 244 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 248 MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 249 GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 251 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 255 MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 256 GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 257 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 258 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 262 MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 263 GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 265 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 268 LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 270 GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 271 GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 272 GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 273 NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 276 LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 280 NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 285 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 287 NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 291 MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 292 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 293 GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 294 NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 295 EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 298 MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 299 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 300 GENOMICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 301 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 303 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 305 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 306 NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 308 NORTH AMERICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 309 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 311 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 312 US: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 313 US: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 315 US: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 316 US: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 US: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 318 US: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 319 US: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 US: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 321 CANADA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 322 CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 324 CANADA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 325 CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 326 CANADA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 327 CANADA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 328 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 CANADA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 330 EUROPE: GENOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 331 EUROPE: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 332 EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 334 EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 335 EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 EUROPE: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 337 EUROPE: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 338 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 340 EUROPE: KEY MACROINDICATORS
  • TABLE 341 GERMANY: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 342 GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 343 GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 344 GERMANY: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 345 GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 GERMANY: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 347 GERMANY: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 348 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 GERMANY: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 350 UK: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 351 UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 353 UK: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 354 UK: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 UK: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 356 UK: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 357 UK: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 UK: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 359 FRANCE: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 360 FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 361 FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 362 FRANCE: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 363 FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 FRANCE: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 365 FRANCE: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 366 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 FRANCE: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 368 ITALY: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 369 ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 371 ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 372 ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 ITALY: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 374 ITALY: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 375 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 ITALY: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 377 SPAIN: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 378 SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 380 SPAIN: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 381 SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 382 SPAIN: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 383 SPAIN: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 384 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 386 REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 387 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 389 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 390 REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 391 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 392 REST OF EUROPE: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 393 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 395 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 396 ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 397 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 399 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 400 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 402 ASIA PACIFIC: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 403 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 405 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 406 CHINA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 407 CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 409 CHINA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 410 CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 CHINA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 412 CHINA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 413 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 CHINA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 415 JAPAN: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 416 JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 418 JAPAN: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 419 JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 JAPAN: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 421 JAPAN: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 422 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 423 JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 424 INDIA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 425 INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 427 INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 428 INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 INDIA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 430 INDIA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 431 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 432 INDIA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 433 AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 434 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 436 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 437 AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 438 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 439 AUSTRALIA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 440 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 442 SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 443 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 445 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 446 SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 448 SOUTH KOREA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 449 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 450 SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 451 REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 452 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 454 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 455 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 456 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 457 REST OF ASIA PACIFIC: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 458 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 460 LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 462 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 463 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 464 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 465 LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 466 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 467 LATIN AMERICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 468 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 469 LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 470 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 471 BRAZIL: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 472 BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 473 BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 474 BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 475 BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 BRAZIL: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 477 BRAZIL: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 478 BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 BRAZIL: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 480 MEXICO: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 481 MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 483 MEXICO: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 484 MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 485 MEXICO: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 486 MEXICO: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 487 MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 488 MEXICO: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 489 REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 490 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 491 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 492 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 493 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 495 REST OF LATIN AMERICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 496 REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 498 MIDDLE EAST: GENOMICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 499 MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 500 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 501 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 502 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 503 MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 505 MIDDLE EAST: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 506 MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 507 MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 508 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 509 GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 510 GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 511 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 513 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 514 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 516 GCC COUNTRIES: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 517 GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 518 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 519 SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 520 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 522 SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 523 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 524 SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 525 SAUDI ARABIA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 526 SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 528 UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 529 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 530 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 531 UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 532 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 534 UNITED ARAB EMIRATES: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 535 UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 536 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 537 REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 538 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 540 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 541 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 543 REST OF GCC COUNTRIES: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 544 REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 546 REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 547 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 548 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 549 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 550 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 551 REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 552 REST OF MIDDLE EAST: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 553 REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 554 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 555 AFRICA: GENOMICS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 556 AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 558 AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 559 AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 560 AFRICA: GENOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 561 AFRICA: GENOMICS MARKET, BY DIAGNOSTIC APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 562 AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2022–2029 (USD MILLION)
  • TABLE 563 AFRICA: GENOMICS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 564 MACROECONOMIC OUTLOOK FOR GENOMICS MARKET IN AFRICA
  • TABLE 565 OVERVIEW OF STRATEGIES ADOPTED BY KEY GENOMICS COMPANIES
  • TABLE 566 GENOMICS MARKET: DEGREE OF COMPETITION
  • TABLE 567 GENOMICS MARKET: REGIONAL FOOTPRINT
  • TABLE 568 GENOMICS MARKET: OFFERING FOOTPRINT, BY PRODUCT TYPE
  • TABLE 569 GENOMICS MARKET: APPLICATION FOOTPRINT
  • TABLE 570 GENOMICS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 571 GENOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 572 GENOMICS MARKET: COMPANY FOOTPRINT (STARTUPS/SMES)
  • TABLE 573 GENOMICS MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 574 GENOMICS MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 575 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 576 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 577 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 578 ILLUMINA, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 579 ILLUMINA, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 580 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 581 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 582 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 583 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 584 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 585 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 586 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 587 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 588 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 589 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 590 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 591 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 592 DANAHER CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 593 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 594 QIAGEN: COMPANY OVERVIEW
  • TABLE 595 QIAGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 596 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 597 QIAGEN: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 598 QIAGEN: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 599 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 600 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 601 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 602 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 603 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 604 REVVITY: COMPANY OVERVIEW
  • TABLE 605 REVVITY: PRODUCTS/SERVICES OFFERED
  • TABLE 606 REVVITY: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 607 REVVITY: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 608 REVVITY: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 609 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
  • TABLE 610 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
  • TABLE 611 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 612 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 613 IQVIA INC.: COMPANY OVERVIEW
  • TABLE 614 IQVIA INC.: SERVICES OFFERED
  • TABLE 615 IQVIA INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 616 IQVIA INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 617 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 618 CHARLES RIVER LABORATORIES: SERVICES OFFERED
  • TABLE 619 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 620 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 621 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 622 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 623 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 624 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 625 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 626 EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 627 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 628 PACBIO: COMPANY OVERVIEW
  • TABLE 629 PACBIO: PRODUCTS/SERVICES OFFERED
  • TABLE 630 PACBIO: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 631 PACBIO: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 632 PACBIO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 633 PACBIO: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 634 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW
  • TABLE 635 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED
  • TABLE 636 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 637 OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 638 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 639 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 640 TAKARA BIO INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 641 TAKARA BIO INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 642 BGI GROUP: COMPANY OVERVIEW
  • TABLE 643 BGI GROUP: PRODUCTS/SERVICES OFFERED
  • TABLE 644 BGI GROUP: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 645 BGI GROUP: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 646 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 647 EPPENDORF SE: COMPANY OVERVIEW
  • TABLE 648 EPPENDORF SE: PRODUCTS/SERVICES OFFERED
  • TABLE 649 EPPENDORF SE: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 650 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 651 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 652 MERCK KGAA: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 653 BD: COMPANY OVERVIEW
  • TABLE 654 BD: PRODUCTS/SERVICES OFFERED
  • TABLE 655 BD: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 656 BD: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 657 ABBOTT: COMPANY OVERVIEW
  • TABLE 658 ABBOTT: PRODUCTS/SERVICES OFFERED
  • TABLE 659 ABBOTT: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 660 10X GENOMICS: COMPANY OVERVIEW
  • TABLE 661 10X GENOMICS: PRODUCTS/SERVICES OFFERED
  • TABLE 662 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 663 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 664 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
  • TABLE 665 NEW ENGLAND BIOLABS: PRODUCT & SERVICE LAUNCHES, JANUARY 2021– SEPTEMBER 2024
  • TABLE 666 NEW ENGLAND BIOLABS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 667 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 668 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 669 PROMEGA CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 670 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 671 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 GENOMICS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 3 GENOMICS PRODUCTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC. (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 GENOMICS PRODUCTS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION
  • FIGURE 10 GENOMICS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 GENOMICS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 GENOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GENOMICS MARKET, BY STUDY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 GENOMICS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 GEOGRAPHIC ANALYSIS: GENOMICS MARKET
  • FIGURE 17 TECHNOLOGICAL ADVANCEMENTS IN GENOME SEQUENCING DRIVING MARKET GROWTH
  • FIGURE 18 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF GENOMICS MARKET IN ASIA PACIFIC IN 2023
  • FIGURE 19 CHINA LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL GENOMICS MARKET DURING FORECAST PERIOD
  • FIGURE 20 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 BURDEN OF HIV INFECTIONS, BY REGION, 2023
  • FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN GENOMICS MARKET
  • FIGURE 24 GENOMICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 VALUE CHAIN OF GENOMICS WORKFLOW: SEQUENCING & ANALYSIS ADD MAXIMUM VALUE TO WORKFLOW
  • FIGURE 26 AVERAGE SELLING PRICE TREND, BY INSTRUMENT, 2021–2023 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021–2023 (USD)
  • FIGURE 28 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD)
  • FIGURE 29 INDICATIVE PRICE TREND OF INSTRUMENTS, BY REGION, 2021–2023 (USD)
  • FIGURE 30 PATENT ANALYSIS FOR GENOMICS MARKET, 2014–2024
  • FIGURE 31 GENOMICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 32 GENOMICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 33 PORTER’S FIVE FORCES ANALYSIS OF GENOMICS MARKET
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 35 KEY BUYING CRITERIA, BY END USER
  • FIGURE 36 RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS, 2018–2024 (USD MILLION)
  • FIGURE 37 IMPACT OF AI/GEN AI ON GENOMICS MARKET
  • FIGURE 38 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET, 2019–2023 (USD MILLION)
  • FIGURE 41 GENOMICS PRODUCT MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 42 GENOMICS SERVICES MARKET RANK, BY KEY PLAYERS (2023)
  • FIGURE 43 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 44 GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 GENOMICS MARKET: COMPANY FOOTPRINT
  • FIGURE 46 GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 ILLUMINA, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 53 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 54 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 REVVITY: COMPANY SNAPSHOT (2023)
  • FIGURE 56 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)
  • FIGURE 57 IQVIA INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 61 PACBIO: COMPANY SNAPSHOT (2023)
  • FIGURE 62 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2023)
  • FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 64 EPPENDORF SE: COMPANY SNAPSHOT (2023)
  • FIGURE 65 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 66 BD: COMPANY SNAPSHOT (2023)
  • FIGURE 67 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 68 10X GENOMICS: COMPANY SNAPSHOT (2023)

This study on the genomics market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the genomics market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

Secondary Research

The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), Nature Reviews Genetics, Nature Methods, Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Genome Research, National Cancer Institute (NCI), European Medicines Agency (EMA), Population Health Research Institute (PHRI), PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global genomics market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global genomics market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing genomics; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the genomics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Genomics is a branch of molecular biology that involves the study of the structure, function, evolution, and mapping of genomes. It applies the techniques of genetics, molecular biology, and bioinformatics to sequence, assemble, and analyze the function and structure of the genome of a selected organism for analysis. Genomics is widely used in diagnostics, drug discovery and development, animal and agricultural research, forensics, and aquaculture research, among others.

Stakeholders

  • Genomics Instrument/System Manufacturing Companies
  • Suppliers and Distributors of Genomic Instruments/Systems, Consumables, and Services
  • Hospitals, Diagnostic Centers, and Medical Colleges
  • Research Institutes
  • Teaching Hospitals and Academic Medical Centers (AMCs)
  • Government Bodies/Municipal Corporations
  • Business Research Firms
  • Venture Capitalists
  • Pharmaceutical and Biopharmaceutical Companies

Report Objectives

  • To define, describe, and forecast the genomics market based on offerings, product type, service type, product by technology, application, end user by product, end user by service, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall genomics market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players in the global genomics market and comprehensively analyze their instruments, reagents, kits, consumables, and services portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the genomics market
  • To benchmark players within the genomics market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Previous Versions of this Report

Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028

Report Code BT 2209
Published in Nov, 2024, By MarketsandMarkets™

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) & Region - Global Forecast to 2025

Report Code BT 2209
Published in Apr, 2023, By MarketsandMarkets™

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025

Report Code BT 2209
Published in Feb, 2021, By MarketsandMarkets™

Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024

Report Code BT 2209
Published in Mar, 2019, By MarketsandMarkets™

Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022

Report Code BT 2209
Published in Oct, 2017, By MarketsandMarkets™

Genomics Market by Product (Instruments, Consumables), by Technology (Sequencing, PCR, Microarray), by Application (Diagnostics, Personalized Medicine), by Process (Library Preparation, Sequencing & Imaging), by End User - Trends & Global Forecasts to 2020

Report Code BT 2209
Published in Feb, 2016, By MarketsandMarkets™

Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018

Report Code BT 2209
Published in Jan, 2014, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Genomics Market

Nathan

Dec, 2022

I am looking for detailed market size valuation pointers for the Genomics Market from 2025 to 2030. Is this data included in your study?.

Andy

Dec, 2022

Can you elaborate more on the global growth dynamics of the Genomics Market?.

Edward

Oct, 2022

Which are the major building blocks for the global growth of Genomics Market?.

Lucas

Oct, 2022

Which of the geographical segment holds the major share of the Genomics Market?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status